[HTML][HTML] Fibrilação atrial (Parte 1): fisiopatologia, fatores de risco e bases terapêuticas
FD Cintra, MJO Figueiredo - Arquivos Brasileiros de Cardiologia, 2021 - SciELO Brasil
A fibrilação atrial é a arritmia sustentada mais comum na prática clínica com predileção
pelas faixas etárias mais avançadas. Com o envelhecimento populacional, as projeções …
pelas faixas etárias mais avançadas. Com o envelhecimento populacional, as projeções …
Atrial fibrillation (Part 1): Pathophysiology, risk factors, and therapeutic basis
FD Cintra, MJO Figueiredo - Arquivos brasileiros de cardiologia, 2021 - SciELO Brasil
Atrial fibrillation is the most common sustained arrhythmia in clinical practice, with a
preference for older age groups. Considering population ageing, the projections for the next …
preference for older age groups. Considering population ageing, the projections for the next …
Atualização das Diretrizes em Cardiogeriatria da Sociedade Brasileira de Cardiologia–2019
GS Feitosa Filho, JM Peixoto, JES Pinheiro… - Arquivos Brasileiros …, 2019 - SciELO Brasil
A partir da segunda metade do século XX, a sobrevivência democratizou-se em grande
parte dos países do mundo. Isto é, mais pessoas estão alcançando as idades mais …
parte dos países do mundo. Isto é, mais pessoas estão alcançando as idades mais …
Prevalence of atrial fibrillation and stroke risk assessment based on telemedicine screening tools in a primary healthcare setting
ERFL de Moraes, C Cirenza, RD Lopes… - European journal of …, 2019 - Elsevier
Background Worldwide atrial fibrillation (AF) prevalence varies between 0.1% and 4.0%,
and has been increasing. Little is known about the prevalence of AF in Brazil. Our objective …
and has been increasing. Little is known about the prevalence of AF in Brazil. Our objective …
[HTML][HTML] Identification of key immune-related genes and immune infiltration in atrial fibrillation with valvular heart disease based on bioinformatics analysis
S Li, Z Jiang, X Chao, C Jiang… - Journal of Thoracic …, 2021 - ncbi.nlm.nih.gov
Background Atrial fibrillation (AF) is the most common persistent arrhythmia. Valvular heart
disease (VHD) and AF frequently coexist. In our study, from performing bioinformatics …
disease (VHD) and AF frequently coexist. In our study, from performing bioinformatics …
[HTML][HTML] Updated geriatric cardiology guidelines of the Brazilian Society of Cardiology-2019
GS Feitosa-Filho, JM Peixoto, JES Pinheiro… - Arquivos brasileiros …, 2019 - ncbi.nlm.nih.gov
Updated Geriatric Cardiology Guidelines of the Brazilian Society of Cardiology - 2019 - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Comparison of the new oral anticoagulants and warfarin in patients with atrial fibrillation and valvular heart disease: systematic review and meta-analysis
Y de Souza Lima Bitar, MG Neto, JAL Filho, LV Pereira… - Drugs in R&D, 2019 - Springer
Abstract Introduction New oral anticoagulants (NOACs) are approved for use in nonvalvular
atrial fibrillation (AF). Objectives This study aimed to evaluate the efficacy and safety of …
atrial fibrillation (AF). Objectives This study aimed to evaluate the efficacy and safety of …
Quality of Oral Anticoagulation in Atrial Fibrillation Patients at a Tertiary Hospital in Brazil
KNDS Malagutte, CFSMP Silveira, FM Reis… - Arquivos Brasileiros …, 2022 - SciELO Brasil
Background: Atrial fibrillation (AF) affects 0.5% to 2.0% of the general population and is
usually associated with cardiac structural diseases, hemodynamic damage, and …
usually associated with cardiac structural diseases, hemodynamic damage, and …
Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and stage 5 chronic kidney disease under dialysis: A systematic review and …
LA de Lucena, MAA Freitas, AKC Souza… - Journal of Thrombosis …, 2024 - Springer
Background In patients with atrial fibrillation (AF) and normal or slightly impaired renal
function, the use of direct oral anticoagulants (DOACs) is preferable to vitamin K antagonists …
function, the use of direct oral anticoagulants (DOACs) is preferable to vitamin K antagonists …
Digoxin in atrial fibrillation: an old topic revisited
F Ferrari, IRMF Santander… - Current cardiology reviews, 2020 - ingentaconnect.com
Digoxin has been used for more than 50 years in patients with Atrial Fibrillation (AF), with the
goal of Controlling Heart Rate (HR) and restoring sinus rhythm. In the last two decades …
goal of Controlling Heart Rate (HR) and restoring sinus rhythm. In the last two decades …